We couldn’t be happier with the success of the congress. Without a doubt, the medical community appreciates the value in these therapies and, ultimately, the patient population benefits from continued solution adoption. We are grateful to all participants and look forward to seeing them and many others in Barcelona in 2008.
Cincinnati, OH (PRWEB) December 13, 2007
On its fourth and final day, the 1st Annual International Therapeutic Temperature Management Congress (TTM Congress) concluded with clear enthusiasm and a sure mark of success: solid plans already are underway for the follow-up event—the 2nd Annual TTM Congress is to be held in Barcelona, Spain from October 1st-3rd, 2008.
This year’s December 4-7th event, held in Cancun, Mexico, drew more than one hundred experts from around the globe to discuss clinical findings and best practices in therapeutic hypothermia and patient temperature modulation. Doctors, researchers, emergency medicine professionals, and solution vendors met to review the most promising induced hypothermia protocols and applications and outlined improving mortality rates and neurological outcome in both adult and pediatric patients affected by myocardial injury and cardiac arrest, spinal cord injury, traumatic brain and other head injury, stroke, asphyxia, and infection.
The exceptional list of presenting participants highlighted the rising visibility and use of temperature-based therapies. Leading investigators and practitioners represented the University Medical Center Utrecht (Netherlands), National Naval Medical Center (Bethesda, MD), Mission Hospital (Mission Viejo, CA), Alfred Hospital (Melbourne, Australia), Children’s Hospital of Pittsburgh (Pittsburgh, PA), Regional One Air Medical Services (Spartanburg, SC), Duke University Medical Center (Durham, NC), University of Miami Miller School of Medicine, William Beaumont Hospital (Royal Oak, MI), University of California San Diego Stroke Center (San Diego, CA), Columbia University Medical Center (New York, NY), University of Texas Southwestern Medical Center (Dallas, TX), and the University of Pittsburgh School of Medicine (Pittsburgh, PA).
And, the list of unrestricted educational grant sponsors for the event demonstrated a level of collaborative thought leadership unique in the medical community. Solution vendors contributing support included Cincinnati Sub-Zero (CSZ) Medical (a founding sponsor), INNERCOOL, Medivance®, Smiths Medical, Cardinal Health, BeneChill, Life Recovery Systems, CEMMA Enterprise, and Gaymar®.
With the conclusion of the event, Mark Beran, Vice President and General Manager of CSZ Medical, founding TTM Congress sponsor and a developer of advanced patient temperature management systems, including highly effective and efficient cooling products, remarked “We couldn’t be happier with the success of the congress. Without a doubt, the medical community appreciates the value in these therapies and, ultimately, the patient population benefits from continued solution adoption. We are grateful to all participants and look forward to seeing them and many others in Barcelona in 2008.”
About Cincinnati Sub-Zero and Cincinnati Sub-Zero, Medical Division
The parent of three separate divisions, Cincinnati Sub-Zero (CSZ) is a leading manufacturer and provider of temperature management products for medical and industrial needs. Cincinnati Sub-Zero, Medical Division has delivered patient temperature management systems to healthcare professionals since 1963, always designed with the patient in mind. The complete line of products includes therapeutic heat therapy, cold therapy units along with a complete line of warming blankets and cooling blankets for body temperature regulation and hyper-hypothermia treatment. Please visit http://www.cszinc.com to learn more about CSZ and http://www.cszmedical.com to learn more about CSZ Medical.
Except for statements of historical fact, the matters discussed in this press release are forward-looking and reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond our control and may cause actual results to differ materially from stated expectations. We undertake no obligation to release publicly the results of any revisions to these forward-looking statements to reflect events or circumstances arising after the date hereof.
Cincinnati Sub-Zero, Medical Division
On behalf of the TTM Congress